Literature DB >> 1729192

Restoration of exocytosis occurs after inactivation of intracellular tetanus toxin.

F Bartels1, H Bigalke.   

Abstract

Tetanus toxin blocks carbachol-stimulated release of noradrenaline from bovine adrenal chromaffin cells in culture, provided it can gain access to the cells. This can be achieved by electropermeabilization of the plasma membrane or by enriching the membrane with exogenous gangliosides which serve as carriers of the toxin. The inhibition of noradrenaline release persists for at least 6 days, even in the presence of specific anti-tetanus toxin antibodies in the culture medium. However, the block is preventable, for the most part, when antibodies enter chromaffin cells during electropermeabilization, before the uptake of the toxin is facilitated by inserting exogenous gangliosides into the plasma membrane 2 days later. This indicates that the antibodies pass into the cells through the physically induced pores and that these intracellular antibodies neutralize incoming tetanus toxin. If, on the other hand, exocytosis has been inhibited by tetanus toxin, it will recover within 3 days, provided specific anti-tetanus toxin antibodies are introduced into the cells by electropermeabilization. The recovery is not linked to a specific route of entry of the toxin. It is concluded that the restoration of noradrenaline release requires not only the intracellular neutralization of tetanus toxin but also the reconstitution of the as yet unknown target molecule of the toxin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729192      PMCID: PMC257536          DOI: 10.1128/iai.60.1.302-307.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Tetanus toxin and spinal inhibition.

Authors:  D R Curtis; W C De Groat
Journal:  Brain Res       Date:  1968-08-26       Impact factor: 3.252

2.  Botulinum A neurotoxin unlike tetanus toxin acts via a neuraminidase sensitive structure.

Authors:  H Bigalke; H Müller; F Dreyer
Journal:  Toxicon       Date:  1986       Impact factor: 3.033

3.  The tetanus toxin light chain inhibits exocytosis.

Authors:  G Ahnert-Hilger; U Weller; M E Dauzenroth; E Habermann; M Gratzl
Journal:  FEBS Lett       Date:  1989-01-02       Impact factor: 4.124

4.  Tetanus toxin: convulsant action on mouse spinal cord neurons in culture.

Authors:  G K Bergey; R L MacDonald; W H Habig; M C Hardegree; P G Nelson
Journal:  J Neurosci       Date:  1983-11       Impact factor: 6.167

Review 5.  Tetanus neurotoxin.

Authors:  N H Wellhöner
Journal:  Rev Physiol Biochem Pharmacol       Date:  1982       Impact factor: 5.545

6.  Management of tetanus.

Authors:  K M Olsen; F C Hiller
Journal:  Clin Pharm       Date:  1987-07

7.  Tetanus toxin: inhibitory action in chromaffin cells is initiated by specified types of gangliosides and promoted in low ionic strength solution.

Authors:  P Marxen; H Bigalke
Journal:  Neurosci Lett       Date:  1989-12-15       Impact factor: 3.046

8.  Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cells.

Authors:  R Penner; E Neher; F Dreyer
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

9.  Tetanus toxin in dissociated spinal cord cultures: long-term characterization of form and action.

Authors:  W H Habig; H Bigalke; G K Bergey; E A Neale; M C Hardegree; P G Nelson
Journal:  J Neurochem       Date:  1986-09       Impact factor: 5.372

10.  Intraspinal distribution and reaction in the grey matter with tetanus toxin of intracisternally injected anti-tetanus toxoid F(ab')2 fragments.

Authors:  G Erdmann; A Hanauske; H H Wellhöner
Journal:  Brain Res       Date:  1981-05-04       Impact factor: 3.252

View more
  2 in total

Review 1.  The use of permeabilized cells to assay protein phosphorylation and catecholamine release.

Authors:  C A Gonçalves; C Gottfried; P R Dunkley
Journal:  Neurochem Res       Date:  2000-06       Impact factor: 3.996

2.  Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells.

Authors:  E Erdal; F Bartels; T Binscheck; G Erdmann; J Frevert; A Kistner; U Weller; J Wever; H Bigalke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.